Alligator Bioscience Signs Immunotherapy Research Collaboration Agreement for 4-1BB
(WorldNews Sweden)

LUND, Sweden, Sept. 17, 2017 : Alligator Bioscience , a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that a research collaboration agreement has been signed with Professor Ignacio Melero, MD, PhD, Center for Applied Medical Research and Clinica Universidad de Navarra, Spain, to further investigate the biology of 4-1BB as a target in cancer immunotherapy. ......